Black Friday Sale - Ends Soon!
-35% Off Everything
SMMT

Summit Therapeutics Inc. (SMMT)

Last Price$18.8(1.0%)
Market Cap$9,756.6M

SMMT overview

Crunching data... Almost there!
1W (2.8%)
1M (15.4%)
6M 527.9%
YTD 599.2%
1Y 846.7%
3Y 265.5%
5Y 1,130.7%
10Y 81.2%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
$0.0$5.0$10.0$15.0$20.0$25.0$30.0Jan'24Feb'24Mar'24Apr'24May'24Jun'24Jul'24Aug'24Sep'24Oct'24Nov'24
Value Sense

SMMT key stats

Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

SMMT Intrinsic value

SMMT Intrinsic value overview

Sign up and unlock this exclusive content!
Sign Up for Free

SMMT Historical intrinsic value

Sign up and unlock this exclusive content!
Sign Up for Free

SMMT Financials

SMMT Income statement

Crunching data... Almost there!

SMMT Balance sheet

Crunching data... Almost there!

SMMT Cash flow statement

Crunching data... Almost there!

SMMT Financial ratios

SMMT Growth

Crunching data... Almost there!

SMMT Returns on capital

Crunching data... Almost there!

Compare with peers: operational metrics

Growth & profitability
Solvency & returns
Crunching data... Almost there!

Wall Street estimates

Price target

Crunching data... Almost there!
Crunching data... Almost there!

EPS Surprises

Crunching data... Almost there!

Looking for the most undervalued companies?

Here's our top picks.

Crunching data... Almost there!

Discover more SMMT fundamentals

Stock picking tips. Ultimate guide 2024
Discover the secrets to successful stock picking in 2024! We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.

FAQ

What is the Intrinsic Value of Summit Therapeutics Inc. (SMMT) stock?

As of today, intrinsic value of Summit Therapeutics Inc. is $1.0.

Is Summit Therapeutics Inc. (SMMT) stock undervalued or overvalued?

As of today, Summit Therapeutics Inc. is overvalued by 94.7%, compared to the current market share price of $18.8.

What is Summit Therapeutics Inc. (SMMT) stock rating?

As of today, Summit Therapeutics Inc. has a stock rating of 3 (out of 10), which is considered Bad.

is Summit Therapeutics Inc. (SMMT) a good stock to buy?

As of today, Summit Therapeutics Inc. has a Bad stock rating, which is 94.7% overvalued. According to Value Sense backtesting, stocks with similar profile tend to underperform the market by 7.7%.